Package 51662-1251-1

{"route": ["INTRAMUSCULAR", "INTRAVENOUS"], "spl_id": "0f8e2789-a18e-bfe6-e063-6394a90abbe9", "openfda": {"unii": ["4182431BJH"], "rxcui": ["1670351"], "spl_set_id": ["7607ddff-2f1c-272c-e053-2991aa0a1ab3"], "manufacturer_name": ["HF Acquisition Co LLC, DBA HealthFirst"]}, "finished": true, "packaging": [{"sample": false, "description": "2 mL in 1 VIAL, SINGLE-DOSE (51662-1251-1)", "package_ndc": "51662-1251-1", "marketing_start_date": "20180916"}, {"sample": false, "description": "25 POUCH in 1 BOX (51662-1251-3)  / 1 VIAL in 1 POUCH (51662-1251-2)  / 2 mL in 1 VIAL", "package_ndc": "51662-1251-3", "marketing_start_date": "20220316"}], "brand_name": "PHENYTOIN SODIUM", "product_id": "51662-1251_0f8e2789-a18e-bfe6-e063-6394a90abbe9", "dosage_form": "INJECTION", "pharm_class": ["Anti-epileptic Agent [EPC]", "Cytochrome P450 1A2 Inducers [MoA]", "Cytochrome P450 2B6 Inducers [MoA]", "Cytochrome P450 2C19 Inducers [MoA]", "Cytochrome P450 2C8 Inducers [MoA]", "Cytochrome P450 2C9 Inducers [MoA]", "Cytochrome P450 2D6 Inducers [MoA]", "Cytochrome P450 3A Inducers [MoA]", "Decreased Central Nervous System Disorganized Electrical Activity [PE]"], "product_ndc": "51662-1251", "generic_name": "PHENYTOIN SODIUM", "labeler_name": "HF Acquisition Co LLC, DBA HealthFirst", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "PHENYTOIN SODIUM", "active_ingredients": [{"name": "PHENYTOIN SODIUM", "strength": "50 mg/mL"}], "application_number": "ANDA084307", "marketing_category": "ANDA", "marketing_start_date": "20180916", "listing_expiration_date": "20261231"}